ScholarGate
Get started
Process / pipelineVeterinary MedicineEpidemiological surveillancePipeline

Zoonotic Disease Surveillance

Also known as: disease monitoring, epidemiological surveillance, public health surveillance

OriginatorVeterinary epidemiology and public healthYear1900s-presentSources3Related methods5

Zoonotic disease surveillance is a systematic population-level monitoring approach that detects, tracks, and analyzes cases of infectious diseases transmissible between animals and humans. Formalized through veterinary epidemiology and integrated with public health systems since the early 1900s, modern surveillance programs employ case detection networks, laboratory confirmation, and data sharing to enable early warning of emerging threats and coordinated disease prevention across animal and human sectors.

Key highlights

  • Early detection of animal disease enables prevention of human cases, reducing mortality and morbidity
  • Population-level data identifies disease trends and emerging transmission patterns not apparent from individual cases
  • Integrated veterinary-public health approach enables coordinated response across sectors
  • Surveillance infrastructure provides capacity for rapid response to novel pathogens or variants
  • Data generated informs disease control policies, vaccine development priorities, and public health messaging

Intuition

This section is available to Pro members. Upgrade to Pro

How it works

This section is available to Pro members. Upgrade to Pro

When to use it

Establish zoonotic disease surveillance for high-consequence diseases (rabies, influenza), endemic diseases in livestock (brucellosis, tuberculosis), and emerging threats identified by international monitoring systems. Essential at animal-human interfaces: farms, wildlife-human contact zones, pet populations, and food production facilities. Particularly critical during disease outbreaks, following unusual case clusters, or when responding to alert systems from international animal health organizations.

Strengths & limitations

Strengths
  • Early detection of animal disease enables prevention of human cases, reducing mortality and morbidity
  • Population-level data identifies disease trends and emerging transmission patterns not apparent from individual cases
  • Integrated veterinary-public health approach enables coordinated response across sectors
  • Surveillance infrastructure provides capacity for rapid response to novel pathogens or variants
  • Data generated informs disease control policies, vaccine development priorities, and public health messaging
Limitations
  • Underreporting is common; clinicians may not recognize mild cases or may not be incentivized to report
  • Diagnostic test availability and accessibility vary; some cases go unconfirmed
  • Population-level surveillance requires sustained funding and political commitment, which may be inconsistent
  • False positives from serological testing can trigger unnecessary control measures; specificity must be high
  • Surveillance primarily captures symptomatic or sick animals; asymptomatic carriers may not be detected

Common pitfalls

This section is available to Pro members. Upgrade to Pro

Applications

This section is available to Pro members. Upgrade to Pro

Frequently asked

What is the difference between passive and active surveillance?

Passive surveillance relies on clinicians or laboratories to voluntarily report cases they encounter. Active surveillance involves systematic testing of populations at risk, regardless of clinical signs. Active surveillance detects more cases but is resource-intensive; both approaches are complementary.

How do I prioritize which diseases to include in a surveillance program?

Consider public health impact (human mortality/morbidity), transmission risk to humans, likelihood of detection in animals, availability of control measures, and geographic distribution. Focus resources on high-impact diseases with prevention potential.

How do I interpret serological survey results in wildlife?

Serological positivity indicates past or present infection but does not specify timing or current infectivity. Combine serology with viral isolation, antigen testing, or PCR for more complete understanding. Consider cross-reactivity and vaccine-induced serology.

What should I do if I detect a novel pathogen in animals?

Report immediately to public health and veterinary authorities, document clinical features and molecular findings, collect additional samples to characterize the pathogen, and implement infection control measures. Collaborate with reference laboratories for confirmation and characterization.

Sources

  1. 1.
    Kahn, C. M. (Ed.). (2002). The Merck Veterinary Manual (9th ed.). Whitehouse Station, NJ: Merck.
    https://www.merckvetmanual.com
  2. 2.
    Zinsstag, J., Schelling, E., Waltner-Toews, D., Tanner, M. (2015). From 'One Medicine' to 'One Health' and systemic approaches to health and well-being. Preventive Veterinary Medicine, 120(1), 12-19.
    https://scholar.google.com/scholar?q=From+%27One+Medicine%27+to+%27One+Health%27+and+systemic+approaches+to+health+and+well-being+Zinsstag
  3. 3.
    Centers for Disease Control and Prevention (CDC). (2023). Zoonotic Diseases. Retrieved from CDC website: https://www.cdc.gov/zoonotic/index.html
    https://www.cdc.gov/zoonotic/index.html

You have read it. What now?

Ask about this methodSimilar methods

Cite this page

ScholarGate. (2026, June 3). Zoonotic Disease Surveillance. ScholarGate. https://scholargate.app/veterinary-medicine/zoonotic-disease-surveillance

Zoonotic Disease Surveillance | ScholarGate